Company intelligence / Profile preview

New Rhein Healthcare Investors

Philadelphia, PA, United States

Ownership: Private
Development stage: Other

Overview

New Rhein is a venture capital firm that applies a private equity approach to life sciences investing, focusing on later-stage, de-risked assets with proven clinical safety and efficacy[3]. The firm manages concentrated portfolios of 5-7 investments per fund with 30-90% ownership stakes[7], emphasizing successful product development execution and commercialization rather than novel scientific discovery[3].

Therapeutic areas: CardiovascularNeurologyInfectious DiseasesPulmonologyMetabolic DisordersMen's Health
Modalities: Small moleculeDeviceBiologic
Industry: Investors

Partnerships

Strategic partnerships with corporate and investor networks

Beyond the preview

Go deeper on New Rhein Healthcare Investors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on New Rhein Healthcare Investors.

Explore the full profile